Award
National Cancer Institute 5R37CA288577-03
Leveraging Biologically Specific PET/MRI Monitoring and Therapeutic Modulation of the Hypoxic Glioblastoma Tumor Immune Microenvironment into Improved Outcomes
Recipient
Oregon Health & Science University
Award Amount
$541,069.00
Ceiling
$541,069.00
Awarded
May 04, 2026
Identifier
5R37CA288577-03
The project aims to develop clinically meaningful imaging technologies and therapeutic approaches for glioblastoma by quantifying and modulating the hypoxic tumor immune microenvironment using novel PET/MRI methods and TAM modulators, including a phase II clinical trial and rodent model studies.
Description
This NIH-funded research project focuses on defining new imaging and therapeutic strategies for glioblastoma using advanced PET/MRI imaging techniques and tumor-associated macrophage (TAM) modulation to improve treatment outcomes and develop new therapeutic strategies.